Literature DB >> 22268649

Severity of Escherichia coli bacteraemia is independent of the intrinsic virulence of the strains assessed in a mouse model.

L Landraud1, F Jauréguy2, E Frapy3, G Guigon4, S Gouriou5, E Carbonnelle6, O Clermont7, E Denamur7, B Picard2, E Lemichez8, S Brisse4, X Nassif9.   

Abstract

Extraintestinal pathogenic Escherichia coli (ExPEC) strains, a major cause of bacteraemia, typically belong to phylogenetic group B2 and express diverse accessory traits that contribute to virulence in mouse infection models. However, their high genomic diversity obscures the relationship between virulence factors and severity of infection in patients. In this study, we analysed concomitantly the strain's expression of virulence in a mouse model, genomic determinants and the clinical severity of infection in 60 bacteraemic patients. We show that bacterial virulence based on an animal model study and virulence factor determination is not correlated with pejorative outcome of E. coli human blood infections.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22268649     DOI: 10.1111/j.1469-0691.2011.03750.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

1.  Impact of virulence genes on sepsis severity and survival in Escherichia coli bacteremia.

Authors:  Marta Mora-Rillo; Natalia Fernández-Romero; Carolina Navarro-San Francisco; Jesús Díez-Sebastián; Maria Pilar Romero-Gómez; Francisco Arnalich Fernández; Jose Ramon Arribas López; Jesús Mingorance
Journal:  Virulence       Date:  2015       Impact factor: 5.882

Review 2.  Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.

Authors:  Amelia E Barber; J Paul Norton; Travis J Wiles; Matthew A Mulvey
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-02       Impact factor: 11.056

Review 3.  Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology.

Authors:  Douglas Kell; Marnie Potgieter; Etheresia Pretorius
Journal:  F1000Res       Date:  2015-07-01

4.  Similarly Lethal Strains of Extraintestinal Pathogenic Escherichia coli Trigger Markedly Diverse Host Responses in a Zebrafish Model of Sepsis.

Authors:  Amelia E Barber; Brittany A Fleming; Matthew A Mulvey
Journal:  mSphere       Date:  2016-04-20       Impact factor: 4.389

5.  Characterization of Asymptomatic Bacteriuria Escherichia coli Isolates in Search of Alternative Strains for Efficient Bacterial Interference against Uropathogens.

Authors:  Christoph Stork; Beáta Kovács; Barnabás Rózsai; Johannes Putze; Matthias Kiel; Ágnes Dorn; Judit Kovács; Szilvia Melegh; Andreas Leimbach; Tamás Kovács; György Schneider; Monika Kerényi; Levente Emödy; Ulrich Dobrindt
Journal:  Front Microbiol       Date:  2018-02-14       Impact factor: 5.640

6.  Phylogroup stability contrasts with high within sequence type complex dynamics of Escherichia coli bloodstream infection isolates over a 12-year period.

Authors:  Guilhem Royer; Mélanie Mercier Darty; Olivier Clermont; Bénédicte Condamine; Cédric Laouenan; Jean-Winoc Decousser; David Vallenet; Agnès Lefort; Victoire de Lastours; Erick Denamur
Journal:  Genome Med       Date:  2021-05-05       Impact factor: 11.117

7.  Assessing the diversity of the virulence potential of Escherichia coli isolated from bacteremia in São Paulo, Brazil.

Authors:  A C M Santos; A C M Zidko; A C Pignatari; R M Silva
Journal:  Braz J Med Biol Res       Date:  2013-10-15       Impact factor: 2.590

8.  Genome wide association study of Escherichia coli bloodstream infection isolates identifies genetic determinants for the portal of entry but not fatal outcome.

Authors:  Erick Denamur; Bénédicte Condamine; Marina Esposito-Farèse; Guilhem Royer; Olivier Clermont; Cédric Laouenan; Agnès Lefort; Victoire de Lastours; Marco Galardini
Journal:  PLoS Genet       Date:  2022-03-24       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.